Sting-dependent activators for treatment of disease
Abstract:
The present disclosure relates, in general, to oligonucleotides that stimulate STING (STimulator of INterferon Genes) activity and increase activity of immune cells. The disclosed STING activators (STAVs) are useful in the treatment of cancer and other immune-mediated conditions.
Public/Granted literature
Information query
Patent Agency Ranking
0/0